ELDN (Eledon Pharmaceuticals Inc.) Yalpi foyda marjasi

ELDN (Eledon Pharmaceuticals, Inc) - kompaniyaning tovar belgisi

Nisbiy yalpi foyda marginasi eksklyuziv Tegoprubart antitelosining Eledon Pharmaceuticals (ELDN) kompaniyasining bozor mavqeiga ta'sirini ko'rsatadi. 0.00 qiymati kompaniya immunologiya sohasidagi innovatsiyalar orqali transplantologlar orasida o'z nufuzini mustahkamlayotgan bir paytda ushbu metrika darajasini aks ettiradi. Biroq, barqaror daromadlar yo'qligi va II/III bosqich klinik sinovlar davomida tashqi moliyalashtirishga bog'liqlik biznesning joriy moliyaviy barqarorligiga ma'lum bosim o'tkazmoqda.

ELDN - Eledon Yalpi rentabellik 04.07.2022 - 20.11.2026 oraligʻida

Eledon Pharmaceuticals (ELDN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Eledon Pharmaceuticals, Inc. ELDN
Eledon Pharmaceuticals, Inc brendining mahsuloti

Eledon Pharmaceuticals (ELDN) kompaniyasining maqsadli antitelalarni ishlab chiqishdagi yuqori ilmiy obro-yuvori uning intellektual kapitali qiymatini va ishlab chiqarish jarayonlarining samaradorligini belgilaydi. Yalpi foyda marjasidagi tendentsiya daromadlar va dori vositalarini ishlab chiqishning bevosita xarajatlari o'rtasidagi farqni aks ettiradi, bu esa investorlarga ushbu metrika tahlili orqali operatsion samaradorlikni va biznesning moliyaviy zaxirasini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOSS|Yalpi foyda bo'yicha rentabellik KalVista Pharmaceuticals, Inc. KALV|Yalpi rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Yalpi foyda marjasi|SVRA - Yalpi rentabellik|Rigel Pharmaceuticals - Yalpi foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Yalpi rentabellik|ATXS - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik enGene Holdings Inc.|RAPT: Yalpi foyda normasi|Yalpi marja JBIO|Yalpi foyda bo'yicha rentabellik aclaristx.com ACRS|Yalpi rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Yalpi foyda marjasi|Cabaletta Bio, Inc - Yalpi marja|Yalpi foyda marjasi Ventyx Biosciences|THTX (theratech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Avalo Therapeutics, Inc|AGEN (Agenus, Inc) - Yalpi marja|Yalpi marja Climb Bio, Inc.|Yalpi rentabellik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Yalpi foyda normasi|Yalpi marja ADAG (Adagene Inc)|IMA - Yalpi foyda bo'yicha rentabellik|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik